Structural analysis of fungal pathogenicity-related casein kinase α subunit, Cka1, in the human fungal pathogen Cryptococcus neoformans

Abstract CK2α is a constitutively active and highly conserved serine/threonine protein kinase that is involved in the regulation of key cellular metabolic pathways and associated with a variety of tumours and cancers. The most well-known CK2α inhibitor is the human clinical trial candidate CX-4945,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Belinda X. Ong, Youngki Yoo, Myeong Gil Han, Jun Bae Park, Myung Kyung Choi, Yeseul Choi, Jeon-Soo Shin, Yong-Sun Bahn, Hyun-Soo Cho
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/53d7b32094a44078b4d9e5fef8d9f205
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:53d7b32094a44078b4d9e5fef8d9f205
record_format dspace
spelling oai:doaj.org-article:53d7b32094a44078b4d9e5fef8d9f2052021-12-02T15:09:20ZStructural analysis of fungal pathogenicity-related casein kinase α subunit, Cka1, in the human fungal pathogen Cryptococcus neoformans10.1038/s41598-019-50678-z2045-2322https://doaj.org/article/53d7b32094a44078b4d9e5fef8d9f2052019-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-50678-zhttps://doaj.org/toc/2045-2322Abstract CK2α is a constitutively active and highly conserved serine/threonine protein kinase that is involved in the regulation of key cellular metabolic pathways and associated with a variety of tumours and cancers. The most well-known CK2α inhibitor is the human clinical trial candidate CX-4945, which has recently shown to exhibit not only anti-cancer, but also anti-fungal properties. This prompted us to work on the CK2α orthologue, Cka1, from the pathogenic fungus Cryptococcus neoformans, which causes life-threatening systemic cryptococcosis and meningoencephalitis mainly in immunocompromised individuals. At present, treatment of cryptococcosis remains a challenge due to limited anti-cryptococcal therapeutic strategies. Hence, expanding therapeutic options for the treatment of the disease is highly clinically relevant. Herein, we report the structures of Cka1-AMPPNP-Mg2+ (2.40 Å) and Cka1-CX-4945 (2.09 Å). Structural comparisons of Cka1-AMPPNP-Mg2+ with other orthologues revealed the dynamic architecture of the N-lobe across species. This may explain for the difference in binding affinities and deviations in protein-inhibitor interactions between Cka1-CX-4945 and human CK2α-CX-4945. Supporting it, in vitro kinase assay demonstrated that CX-4945 inhibited human CK2α much more efficiently than Cka1. Our results provide structural insights into the design of more selective inhibitors against Cka1.Belinda X. OngYoungki YooMyeong Gil HanJun Bae ParkMyung Kyung ChoiYeseul ChoiJeon-Soo ShinYong-Sun BahnHyun-Soo ChoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Belinda X. Ong
Youngki Yoo
Myeong Gil Han
Jun Bae Park
Myung Kyung Choi
Yeseul Choi
Jeon-Soo Shin
Yong-Sun Bahn
Hyun-Soo Cho
Structural analysis of fungal pathogenicity-related casein kinase α subunit, Cka1, in the human fungal pathogen Cryptococcus neoformans
description Abstract CK2α is a constitutively active and highly conserved serine/threonine protein kinase that is involved in the regulation of key cellular metabolic pathways and associated with a variety of tumours and cancers. The most well-known CK2α inhibitor is the human clinical trial candidate CX-4945, which has recently shown to exhibit not only anti-cancer, but also anti-fungal properties. This prompted us to work on the CK2α orthologue, Cka1, from the pathogenic fungus Cryptococcus neoformans, which causes life-threatening systemic cryptococcosis and meningoencephalitis mainly in immunocompromised individuals. At present, treatment of cryptococcosis remains a challenge due to limited anti-cryptococcal therapeutic strategies. Hence, expanding therapeutic options for the treatment of the disease is highly clinically relevant. Herein, we report the structures of Cka1-AMPPNP-Mg2+ (2.40 Å) and Cka1-CX-4945 (2.09 Å). Structural comparisons of Cka1-AMPPNP-Mg2+ with other orthologues revealed the dynamic architecture of the N-lobe across species. This may explain for the difference in binding affinities and deviations in protein-inhibitor interactions between Cka1-CX-4945 and human CK2α-CX-4945. Supporting it, in vitro kinase assay demonstrated that CX-4945 inhibited human CK2α much more efficiently than Cka1. Our results provide structural insights into the design of more selective inhibitors against Cka1.
format article
author Belinda X. Ong
Youngki Yoo
Myeong Gil Han
Jun Bae Park
Myung Kyung Choi
Yeseul Choi
Jeon-Soo Shin
Yong-Sun Bahn
Hyun-Soo Cho
author_facet Belinda X. Ong
Youngki Yoo
Myeong Gil Han
Jun Bae Park
Myung Kyung Choi
Yeseul Choi
Jeon-Soo Shin
Yong-Sun Bahn
Hyun-Soo Cho
author_sort Belinda X. Ong
title Structural analysis of fungal pathogenicity-related casein kinase α subunit, Cka1, in the human fungal pathogen Cryptococcus neoformans
title_short Structural analysis of fungal pathogenicity-related casein kinase α subunit, Cka1, in the human fungal pathogen Cryptococcus neoformans
title_full Structural analysis of fungal pathogenicity-related casein kinase α subunit, Cka1, in the human fungal pathogen Cryptococcus neoformans
title_fullStr Structural analysis of fungal pathogenicity-related casein kinase α subunit, Cka1, in the human fungal pathogen Cryptococcus neoformans
title_full_unstemmed Structural analysis of fungal pathogenicity-related casein kinase α subunit, Cka1, in the human fungal pathogen Cryptococcus neoformans
title_sort structural analysis of fungal pathogenicity-related casein kinase α subunit, cka1, in the human fungal pathogen cryptococcus neoformans
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/53d7b32094a44078b4d9e5fef8d9f205
work_keys_str_mv AT belindaxong structuralanalysisoffungalpathogenicityrelatedcaseinkinaseasubunitcka1inthehumanfungalpathogencryptococcusneoformans
AT youngkiyoo structuralanalysisoffungalpathogenicityrelatedcaseinkinaseasubunitcka1inthehumanfungalpathogencryptococcusneoformans
AT myeonggilhan structuralanalysisoffungalpathogenicityrelatedcaseinkinaseasubunitcka1inthehumanfungalpathogencryptococcusneoformans
AT junbaepark structuralanalysisoffungalpathogenicityrelatedcaseinkinaseasubunitcka1inthehumanfungalpathogencryptococcusneoformans
AT myungkyungchoi structuralanalysisoffungalpathogenicityrelatedcaseinkinaseasubunitcka1inthehumanfungalpathogencryptococcusneoformans
AT yeseulchoi structuralanalysisoffungalpathogenicityrelatedcaseinkinaseasubunitcka1inthehumanfungalpathogencryptococcusneoformans
AT jeonsooshin structuralanalysisoffungalpathogenicityrelatedcaseinkinaseasubunitcka1inthehumanfungalpathogencryptococcusneoformans
AT yongsunbahn structuralanalysisoffungalpathogenicityrelatedcaseinkinaseasubunitcka1inthehumanfungalpathogencryptococcusneoformans
AT hyunsoocho structuralanalysisoffungalpathogenicityrelatedcaseinkinaseasubunitcka1inthehumanfungalpathogencryptococcusneoformans
_version_ 1718387814799769600